European Association of Preventive Cardiology
Showing 24 of 5910 results
ESC Journals
World Hypertension League: education and awareness about the most important risk factor. An interview with prof Gianfranco Parati, president of WHL
15 May 2026
ESC Journals
The genie is out: blood pressure wearables and the evidence gap
15 May 2026
ESC Journals
Closing the gap in hypertension: from guidelines to real-world prevention
15 May 2026
ESC Journals
Fibrosis and hypertension: association but not causation
7 May 2026
Webinar
Climate change: the role of healthcare professionals and individuals to improve outcomes
4 May 2026
Congress
ESC Preventive Cardiology 2026
23 April 2026
ESC Journals
The expanding frontiers of cardiac rehabilitation: bridging innovation and real-world practice
22 April 2026
ESC Journals
Revolutionizing cardiac rehabilitation: France’s new paths beyond the centre
22 April 2026
ESC Journals
From hospital to smartphone: the future of cardiac rehabilitation
22 April 2026
ESC Journals
Cardiac telerehabilitation: time for implementation
22 April 2026
ESC Journals
Cooling the fire: targeting inflammation in cardiovascular diseases
27 March 2026
ESC Journals
From residual risk to real risk: why implementation fails when we misunderstand the problem
20 March 2026
ESC Journals
PO99 <br />Re-classification of LDLR Variants through High-Throughput Functional Characterisation: Advancing Diagnosis in Familial Hypercholesterolaemia
19 March 2026
ESC Journals
PO98 <br />Sudden cardiac arrest: the hidden genetic danger
19 March 2026
ESC Journals
PO97 <br />Predicaments in diagnosing victim of sudden cardiac arrest in an adolescent
19 March 2026
ESC Journals
PO96 <br />Diving into Genetics: Dilated Cardiomyopathy with Left Ventricular Hypertrabeculation – Case Study and Familial Implications
19 March 2026
ESC Journals
PO95 <br />From myocarditis to non-dilated left ventricular cardiomyopathy: the decisive role of genetic testing in a young patient with syncope
19 March 2026
ESC Journals
PO94 <br />Beyond Genotype in Hypertrophic Cardiomyopathy: CMR and Biomarkers Drive Risk, Genetics Shapes Phenotype
19 March 2026
ESC Journals
PO93 <br />Shared splicing dysregulation in heart failure associated with dilated and ischemic cardiomyopathy and spatial specificity across cardiac regions
19 March 2026
ESC Journals
PO92 <br />Expanding the genetic landscape of hypertrophic cardiomyopathy: patient-derived cardiomyocytes with deep intronic MYBPC3 variants recapitulate key disease features in vitro
19 March 2026
ESC Journals
PO91 <br />Beyond SNVs and Indels: The Contribution of CNVs to Improve Diagnostic Outcomes in Cardiogenetics
19 March 2026
ESC Journals
PO90 <br />Is the polygenic risk score merely a research tool, or will it hold the potential to be a clinical instrument in cardiovascular prevention?
19 March 2026
ESC Journals
PO89 <br />Neonatal LQT3 due to de novo SCN5A: p.(A1656V) variant: genotype-directed therapy
19 March 2026
ESC Journals
PO88 <br />Mavacamten in Noonan syndrome: clinical benefits mediated by an off-target mechanism
19 March 2026

